Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
May-2018 Volume 15 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2018 Volume 15 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Review

Molecular mechanisms of suppressor of fused in regulating the hedgehog signalling pathway (Review)

  • Authors:
    • Dengliang Huang
    • Yiting Wang
    • Jiabin Tang
    • Shiwen Luo
  • View Affiliations / Copyright

    Affiliations: Center for Experimental Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China
  • Pages: 6077-6086
    |
    Published online on: March 1, 2018
       https://doi.org/10.3892/ol.2018.8142
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Highly conserved throughout evolution, the hedgehog (Hh) signalling pathway has been demonstrated to be involved in embryonic development, stem cell maintenance and tissue homeostasis in animals ranging from invertebrates to vertebrates. In the human body, a variety of cancer types are associated with the aberrantly activated Hh signalling pathway. Multiple studies have revealed suppressor of fused (Sufu) as a key negative regulator of this signalling pathway. In vertebrates, Sufu primarily functions as a tumor suppressor factor by interacting with and inhibiting glioma‑associated oncogene homologues (GLIs), which are the terminal transcription factors of the Hh signalling pathway and belong to the Kruppel family of zinc finger proteins; by contrast, the regulation of Sufu itself remains relatively unclear. In the present review article, we focus on the effects of Sufu on the Hh signalling pathway in tumourigenesis and the molecular mechanisms underlying the regulation of GLI by Sufu. In addition, the factors modulating the activity of Sufu at post‑transcriptional levels are also discussed.
View Figures

Figure 1

Figure 2

View References

1 

Nüsslein-Volhard C and Wieschaus E: Mutations affecting segment number and polarity in Drosophila. Nature. 287:795–801. 1980. View Article : Google Scholar : PubMed/NCBI

2 

Briscoe J and Thérond PP: The mechanisms of Hedgehog signalling and its roles in development and disease. Nat Rev Mol Cell Biol. 14:416–429. 2013. View Article : Google Scholar : PubMed/NCBI

3 

Ingham PW, Nakano Y and Seger C: Mechanisms and functions of Hedgehog signalling across the metazoa. Nat Rev Genet. 12:393–406. 2011. View Article : Google Scholar : PubMed/NCBI

4 

Varjosalo M and Taipale J: Hedgehog: Functions and mechanisms. Genes Dev. 22:2454–2472. 2008. View Article : Google Scholar : PubMed/NCBI

5 

Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein EH Jr and Scott MP: Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science. 272:1668–1671. 1996. View Article : Google Scholar : PubMed/NCBI

6 

Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Unden AB, Gillies S, et al: Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell. 85:841–851. 1996. View Article : Google Scholar : PubMed/NCBI

7 

Barakat MT, Humke EW and Scott MP: Learning from Jekyll to control Hyde: Hedgehog signaling in development and cancer. Trends Mol Med. 16:337–348. 2010. View Article : Google Scholar : PubMed/NCBI

8 

Chen Q, Gao G and Luo S: Hedgehog signaling pathway and ovarian cancer. Chin J Cancer Res. 25:346–353. 2013.PubMed/NCBI

9 

Zeng C, Wang Y, Lu Q, Chen J, Zhang J, Liu T, Lv N and Luo S: SPOP suppresses tumorigenesis by regulating Hedgehog/Gli2 signaling pathway in gastric cancer. J Exp Clin Cancer Res. 33:752014. View Article : Google Scholar : PubMed/NCBI

10 

Shi C, Huang D, Lu N, Chen D, Zhang M, Yan Y, Deng L, Lu Q, Lu H and Luo S: Aberrantly activated Gli2-KIF20A axis is crucial for growth of hepatocellular carcinoma and predicts poor prognosis. Oncotarget. 7:26206–26219. 2016.PubMed/NCBI

11 

Shin K, Lim A, Zhao C, Sahoo D, Pan Y, Spiekerkoetter E, Liao JC and Beachy PA: Hedgehog signaling restrains bladder cancer progression by eliciting stromal production of urothelial differentiation factors. Cancer Cell. 26:521–533. 2014. View Article : Google Scholar : PubMed/NCBI

12 

Fei DL, Sanchez-Mejias A, Wang Z, Flaveny C, Long J, Singh S, Rodriguez-Blanco J, Tokhunts R, Giambelli C, Briegel KJ, et al: Hedgehog signaling regulates bladder cancer growth and tumorigenicity. Cancer Res. 72:4449–4458. 2012. View Article : Google Scholar : PubMed/NCBI

13 

Rimkus TK, Carpenter RL, Qasem S, Chan M and Lo HW: Targeting the sonic hedgehog signaling pathway: Review of smoothened and GLI inhibitors. Cancers (Basel). 8:pii: E22. 2016. View Article : Google Scholar : PubMed/NCBI

14 

Hui CC and Angers S: Gli proteins in development and disease. Annu Rev Cell Dev Biol. 27:513–537. 2011. View Article : Google Scholar : PubMed/NCBI

15 

Svärd J, Heby-Henricson K, Persson-Lek M, Rozell B, Lauth M, Bergström A, Ericson J, Toftgård R and Teglund S: Genetic elimination of suppressor of fused reveals an essential repressor function in the mammalian hedgehog signaling pathway. Dev Cell. 10:187–197. 2006. View Article : Google Scholar : PubMed/NCBI

16 

Préat T: Characterization of suppressor of fused, a complete suppressor of the fused segment polarity gene of Drosophila melanogaster. Genetics. 132:725–736. 1992.PubMed/NCBI

17 

Babcock DT, Shi S, Jo J, Shaw M, Gutstein HB and Galko MJ: Hedgehog signaling regulates nociceptive sensitization. Curr Biol. 21:1525–1533. 2011. View Article : Google Scholar : PubMed/NCBI

18 

Teperino R, Amann S, Bayer M, McGee SL, Loipetzberger A, Connor T, Jaeger C, Kammerer B, Winter L, Wiche G, et al: Hedgehog partial agonism drives Warburg-like metabolism in muscle and brown fat. Cell. 151:414–426. 2012. View Article : Google Scholar : PubMed/NCBI

19 

Teperino R, Aberger F, Esterbauer H, Riobo N and Pospisilik JA: Canonical and non-canonical Hedgehog signalling and the control of metabolism. Semin Cell Dev Biol. 33:81–92. 2014. View Article : Google Scholar : PubMed/NCBI

20 

Hooper JE: Distinct pathways for autocrine and paracrine Wingless signalling in Drosophila embryos. Nature. 372:461–464. 1994. View Article : Google Scholar : PubMed/NCBI

21 

Pham A, Therond P, Alves G, Tournier FB, Busson D, Lamour-Isnard C, Bouchon BL, Préat T and Tricoire H: The suppressor of fused gene encodes a novel PEST protein involved in Drosophila segment polarity establishment. Genetics. 140:587–598. 1995.PubMed/NCBI

22 

Monnier V, Dussillol F, Alves G, Lamour-Isnard C and Plessis A: Suppressor of fused links fused and Cubitus interruptus on the hedgehog signalling pathway. Curr Biol. 8:583–586. 1998. View Article : Google Scholar : PubMed/NCBI

23 

Delattre M, Briand S, Paces-Fessy M and Blanchet-Tournier MF: The Suppressor of fused gene, involved in Hedgehog signal transduction in Drosophila, is conserved in mammals. Dev Genes Evol. 209:294–300. 1999. View Article : Google Scholar : PubMed/NCBI

24 

Pearse RV II, Collier LS, Scott MP and Tabin CJ: Vertebrate homologs of Drosophila suppressor of fused interact with the gli family of transcriptional regulators. Dev Biol. 212:323–336. 1999. View Article : Google Scholar : PubMed/NCBI

25 

Ding Q, Fukami Si, Meng X, Nishizaki Y, Zhang X, Sasaki H, Dlugosz A, Nakafuku M and Hui Cc: Mouse suppressor of fused is a negative regulator of sonic hedgehog signaling and alters the subcellular distribution of Gli1. Curr Biol. 9:1119–1122. 1999. View Article : Google Scholar : PubMed/NCBI

26 

Simon-Chazottes D, Paces-Fessy M, Lamour-Isnard C, Guénet JL and Blanchet-Tournier MF: Genomic organization, chromosomal assignment, and expression analysis of the mouse suppressor of fused gene (Sufu) coding a Gli protein partner. Mamm Genome. 11:614–621. 2000. View Article : Google Scholar : PubMed/NCBI

27 

Stone DM, Murone M, Luoh S, Ye W, Armanini MP, Gurney A, Phillips H, Brush J, Goddard A, de Sauvage FJ and Rosenthal A: Characterization of the human suppressor of fused, a negative regulator of the zinc-finger transcription factor Gli. J Cell Sci. 112:4437–4448. 1999.PubMed/NCBI

28 

Rasheed BK, McLendon RE, Friedman HS, Friedman AH, Fuchs HE, Bigner DD and Bigner SH: Chromosome 10 deletion mapping in human gliomas: A common deletion region in 10q25. Oncogene. 10:2243–2246. 1995.PubMed/NCBI

29 

Gray IC, Phillips SM, Lee SJ, Neoptolemos JP, Weissenbach J and Spurr NK: Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res. 55:4800–4803. 1995.PubMed/NCBI

30 

Cherry AL, Finta C, Karlström M, Jin Q, Schwend T, Astorga-Wells J, Zubarev RA, Del Campo M, Criswell AR, de Sanctis D, et al: Structural basis of SUFU-GLI interaction in human Hedgehog signalling regulation. Acta Crystallogr D Biol Crystallogr. 69:2563–2579. 2013. View Article : Google Scholar : PubMed/NCBI

31 

Zhang Y, Fu L, Qi X, Zhang Z, Xia Y, Jia J, Jiang J, Zhao Y and Wu G: Structural insight into the mutual recognition and regulation between Suppressor of Fused and Gli/Ci. Nat Commun. 4:26082013. View Article : Google Scholar : PubMed/NCBI

32 

Lee Y, Kawagoe R, Sasai K, Li Y, Russell HR, Curran T and McKinnon PJ: Loss of suppressor-of-fused function promotes tumorigenesis. Oncogene. 26:6442–6447. 2007. View Article : Google Scholar : PubMed/NCBI

33 

Ogino S, Gulley ML, den Dunnen JT and Wilson RB: Association for Molecular Patholpogy Training and Education Committtee: Standard mutation nomenclature in molecular diagnostics: Practical and educational challenges. J Mol Diagn. 9:1–6. 2007. View Article : Google Scholar : PubMed/NCBI

34 

Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI

35 

Brugières L, Remenieras A, Pierron G, Varlet P, Forget S, Byrde V, Bombled J, Puget S, Caron O, Dufour C, et al: High frequency of germline SUFU mutations in children with desmoplastic/nodular medulloblastoma younger than 3 years of age. J Clin Oncol. 30:2087–2093. 2012. View Article : Google Scholar : PubMed/NCBI

36 

Ng D, Stavrou T, Liu L, Taylor MD, Gold B, Dean M, Kelley MJ, Dubovsky EC, Vezina G, Nicholson HS, et al: Retrospective family study of childhood medulloblastoma. Am J Med Genet A. 134:399–403. 2005. View Article : Google Scholar : PubMed/NCBI

37 

Taylor MD, Liu L, Raffel C, Hui CC, Mainprize TG, Zhang X, Agatep R, Chiappa S, Gao L, Lowrance A, et al: Mutations in SUFU predispose to medulloblastoma. Nat Genet. 31:306–310. 2002. View Article : Google Scholar : PubMed/NCBI

38 

Smith MJ, Beetz C, Williams SG, Bhaskar SS, O'Sullivan J, Anderson B, Daly SB, Urquhart JE, Bholah Z, Oudit D, et al: Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations. J Clin Oncol. 32:4155–4161. 2014. View Article : Google Scholar : PubMed/NCBI

39 

Slade I, Murray A, Hanks S, Kumar A, Walker L, Hargrave D, Douglas J, Stiller C, Izatt L and Rahman N: Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma. Fam Cancer. 10:337–342. 2011. View Article : Google Scholar : PubMed/NCBI

40 

Brugières L, Pierron G, Chompret A, Paillerets BB, Di Rocco F, Varlet P, Pierre-Kahn A, Caron O, Grill J and Delattre O: Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations. J Med Genet. 47:142–144. 2010. View Article : Google Scholar : PubMed/NCBI

41 

Heby-Henricson K, Bergström A, Rozell B, Toftgård R and Teglund S: Loss of Trp53 promotes medulloblastoma development but not skin tumorigenesis in Sufu heterozygous mutant mice. Mol Carcinog. 51:754–760. 2012. View Article : Google Scholar : PubMed/NCBI

42 

Svärd J, Rozell B, Toftgård R and Teglund S: Tumor suppressor gene co-operativity in compound Patched1 and suppressor of fused heterozygous mutant mice. Mol Carcinog. 48:408–419. 2009. View Article : Google Scholar : PubMed/NCBI

43 

Koch A, Waha A, Hartmann W, Milde U, Goodyer CG, Sörensen N, Berthold F, Digon-Söntgerath B, Krätzschmar J, Wiestler OD and Pietsch T: No evidence for mutations or altered expression of the Suppressor of Fused gene (SUFU) in primitive neuroectodermal tumours. Neuropathol Appl Neurobiol. 30:532–539. 2004. View Article : Google Scholar : PubMed/NCBI

44 

Scott DK, Straughton D, Cole M, Bailey S, Ellison DW and Clifford SC: Identification and analysis of tumor suppressor loci at chromosome 10q23.3-10q25.3 in medulloblastoma. Cell Cycle. 5:2381–2389. 2006. View Article : Google Scholar : PubMed/NCBI

45 

Zabidi MA and Stark A: Regulatory enhancer-core-promoter communication via transcription factors and cofactors. Trends Genet. 32:801–814. 2016. View Article : Google Scholar : PubMed/NCBI

46 

Spurrell CH, Dickel DE and Visel A: The ties that bind: Mapping the dynamic enhancer-promoter interactome. Cell. 167:1163–1166. 2016. View Article : Google Scholar : PubMed/NCBI

47 

Aavikko M, Li SP, Saarinen S, Alhopuro P, Kaasinen E, Morgunova E, Li Y, Vesanen K, Smith MJ, Evans DG, et al: Loss of SUFU function in familial multiple meningioma. Am J Hum Genet. 91:520–526. 2012. View Article : Google Scholar : PubMed/NCBI

48 

Lim CB, Prêle CM, Cheah HM, Cheng YY, Klebe S, Reid G, Watkins DN, Baltic S, Thompson PJ and Mutsaers SE: Mutational analysis of hedgehog signaling pathway genes in human malignant mesothelioma. PLoS One. 8:e666852013. View Article : Google Scholar : PubMed/NCBI

49 

Tostar U, Malm CJ, Meis-Kindblom JM, Kindblom LG, Toftgård R and Undén AB: Deregulation of the hedgehog signalling pathway: A possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development. J Pathol. 208:17–25. 2006. View Article : Google Scholar : PubMed/NCBI

50 

Yin WC, Li ZJ and Hui CC: BCC or not: Sufu keeps it in check. Oncoscience. 2:77–78. 2015. View Article : Google Scholar : PubMed/NCBI

51 

Schulman JM, Oh DH, Sanborn JZ, Pincus L, McCalmont TH and Cho RJ: Multiple hereditary infundibulocystic basal cell carcinoma syndrome associated with a germline SUFU mutation. JAMA Dermatol. 152:323–327. 2016. View Article : Google Scholar : PubMed/NCBI

52 

Reifenberger J, Wolter M, Knobbe CB, Köhler B, Schönicke A, Scharwächter C, Kumar K, Blaschke B, Ruzicka T and Reifenberger G: Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol. 152:43–51. 2005. View Article : Google Scholar : PubMed/NCBI

53 

Mann K, Magee J, Guillaud-Bataille M, Blondel C, Bressac-de Paillerets B, Yeatman J and Winship I: Multiple skin hamartomata: A possible novel clinical presentation of SUFU neoplasia syndrome. Fam Cancer. 14:151–155. 2015. View Article : Google Scholar : PubMed/NCBI

54 

Sheng T, Li C, Zhang X, Chi S, He N, Chen K, McCormick F, Gatalica Z and Xie J: Activation of the hedgehog pathway in advanced prostate cancer. Mol Cancer. 3:292004. View Article : Google Scholar : PubMed/NCBI

55 

Pastorino L, Ghiorzo P, Nasti S, Battistuzzi L, Cusano R, Marzocchi C, Garrè ML, Clementi M and Scarrà GB: Identification of a SUFU germline mutation in a family with Gorlin syndrome. Am J Med Genet A. 149A:1539–1543. 2009. View Article : Google Scholar : PubMed/NCBI

56 

Ruel L and Thérond PP: Variations in Hedgehog signaling: Divergence and perpetuation in Sufu regulation of Gli. Genes Dev. 23:1843–1848. 2009. View Article : Google Scholar : PubMed/NCBI

57 

McDermott A, Gustafsson M, Elsam T, Hui CC, Emerson CP Jr and Borycki AG: Gli2 and Gli3 have redundant and context-dependent function in skeletal muscle formation. Development. 132:345–357. 2005. View Article : Google Scholar : PubMed/NCBI

58 

Pan Y, Wang C and Wang B: Phosphorylation of Gli2 by protein kinase A is required for Gli2 processing and degradation and the Sonic Hedgehog-regulated mouse development. Dev Biol. 326:177–189. 2009. View Article : Google Scholar : PubMed/NCBI

59 

Goetz SC and Anderson KV: The primary cilium: A signalling centre during vertebrate development. Nat Rev Genet. 11:331–344. 2010. View Article : Google Scholar : PubMed/NCBI

60 

Wen X, Lai CK, Evangelista M, Hongo JA, de Sauvage FJ and Scales SJ: Kinetics of hedgehog-dependent full-length Gli3 accumulation in primary cilia and subsequent degradation. Mol Cell Biol. 30:1910–1922. 2010. View Article : Google Scholar : PubMed/NCBI

61 

Endoh-Yamagami S, Evangelista M, Wilson D, Wen X, Theunissen JW, Phamluong K, Davis M, Scales SJ, Solloway MJ, de Sauvage FJ and Peterson AS: The mammalian Cos2 homolog Kif7 plays an essential role in modulating Hh signal transduction during development. Curr Biol. 19:1320–1326. 2009. View Article : Google Scholar : PubMed/NCBI

62 

Cheung HO, Zhang X, Ribeiro A, Mo R, Makino S, Puviindran V, Law KK, Briscoe J and Hui CC: The kinesin protein Kif7 is a critical regulator of Gli transcription factors in mammalian hedgehog signaling. Sci Signal. 2:ra292009. View Article : Google Scholar : PubMed/NCBI

63 

Liu X, Wang X, Du W, Chen L, Wang G, Cui Y, Liu Y, Dou Z, Wang H, Zhang P, et al: Suppressor of fused (Sufu) represses Gli1 transcription and nuclear accumulation, inhibits glioma cell proliferation, invasion and vasculogenic mimicry, improving glioma chemo-sensitivity and prognosis. Oncotarget. 5:11681–11694. 2014. View Article : Google Scholar : PubMed/NCBI

64 

Szczepny A, Wagstaff KM, Dias M, Gajewska K, Wang C, Davies RG, Kaur G, Ly-Huynh J, Loveland KL and Jans DA: Overlapping binding sites for importin b1 and suppressor of fused (SuFu) on glioma-associated oncogene homologue 1 (Gli1) regulate its nuclear localization. Biochem J. 461:469–476. 2014. View Article : Google Scholar : PubMed/NCBI

65 

Shi Q, Han Y and Jiang J: Suppressor of fused impedes Ci/Gli nuclear import by opposing Trn/Kapb2 in Hedgehog signaling. J Cell Sci. 127:1092–1103. 2014. View Article : Google Scholar : PubMed/NCBI

66 

Han Y, Shi Q and Jiang J: Multisite interaction with Sufu regulates Ci/Gli activity through distinct mechanisms in Hh signal transduction. Proc Natl Acad Sci USA. 112:6383–6388. 2015. View Article : Google Scholar : PubMed/NCBI

67 

Wang C, Pan Y and Wang B: Suppressor of fused and Spop regulate the stability, processing and function of Gli2 and Gli3 full-length activators but not their repressors. Development. 137:2001–2009. 2010. View Article : Google Scholar : PubMed/NCBI

68 

Tempé D, Casas M, Karaz S, Blanchet-Tournier MF and Concordet JP: Multisite protein kinase A and glycogen synthase kinase 3beta phosphorylation leads to Gli3 ubiquitination by SCFbetaTrCP. Mol Cell Biol. 26:4316–4326. 2006. View Article : Google Scholar : PubMed/NCBI

69 

Wang B and Li Y: Evidence for the direct involvement of {beta}TrCP in Gli3 protein processing. Proc Natl Acad Sci USA. 103:33–38. 2006. View Article : Google Scholar : PubMed/NCBI

70 

Pan Y, Bai CB, Joyner AL and Wang B: Sonic hedgehog signaling regulates Gli2 transcriptional activity by suppressing its processing and degradation. Mol Cell Biol. 26:3365–3377. 2006. View Article : Google Scholar : PubMed/NCBI

71 

Wang B, Fallon JF and Beachy PA: Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb. Cell. 100:423–434. 2000. View Article : Google Scholar : PubMed/NCBI

72 

Tukachinsky H, Lopez LV and Salic A: A mechanism for vertebrate Hedgehog signaling: Recruitment to cilia and dissociation of SuFu-Gli protein complexes. J Cell Biol. 191:415–428. 2010. View Article : Google Scholar : PubMed/NCBI

73 

Yue S, Chen Y and Cheng SY: Hedgehog signaling promotes the degradation of tumor suppressor Sufu through the ubiquitin-proteasome pathway. Oncogene. 28:492–499. 2009. View Article : Google Scholar : PubMed/NCBI

74 

Raducu M, Fung E, Serres S, Infante P, Barberis A, Fischer R, Bristow C, Thézénas ML, Finta C, Christianson JC, et al: SCF (Fbxl17) ubiquitylation of Sufu regulates Hedgehog signaling and medulloblastoma development. EMBO J. 35:1400–1416. 2016. View Article : Google Scholar : PubMed/NCBI

75 

Zhang Z, Shen L, Law K, Zhang Z, Liu X, Hua H, Li S, Huang H, Yue S, Hui CC and Cheng SY: Suppressor of fused chaperones Gli proteins to generate transcriptional responses to sonic hedgehog signaling. Mol Cell Biol. 37:pii: e00421. –16. 2017. View Article : Google Scholar

76 

Santos N and Reiter JF: A central region of Gli2 regulates its localization to the primary cilium and transcriptional activity. J Cell Sci. 127:1500–1510. 2014. View Article : Google Scholar : PubMed/NCBI

77 

Li BI, Matteson PG, Ababon MF, Nato AQ Jr, Lin Y, Nanda V, Matise TC and Millonig JH: The orphan GPCR, Gpr161, regulates the retinoic acid and canonical Wnt pathways during neurulation. Dev Biol. 402:17–31. 2015. View Article : Google Scholar : PubMed/NCBI

78 

Pal K, Hwang SH, Somatilaka B, Badgandi H, Jackson PK, DeFea K and Mukhopadhyay S: Smoothened determines b-arrestin-mediated removal of the G protein-coupled receptor Gpr161 from the primary cilium. J Cell Biol. 212:861–875. 2016. View Article : Google Scholar : PubMed/NCBI

79 

Blair HJ, Tompson S, Liu YN, Campbell J, MacArthur K, Ponting CP, Ruiz-Perez VL and Goodship JA: Evc2 is a positive modulator of Hedgehog signalling that interacts with Evc at the cilia membrane and is also found in the nucleus. BMC Biol. 9:142011. View Article : Google Scholar : PubMed/NCBI

80 

Yang C, Chen W, Chen Y and Jiang J: Smoothened transduces Hedgehog signal by forming a complex with Evc/Evc2. Cell Res. 22:1593–1604. 2012. View Article : Google Scholar : PubMed/NCBI

81 

Caparrós-Martín JA, Valencia M, Reytor E, Pacheco M, Fernandez M, Perez-Aytes A, Gean E, Lapunzina P, Peters H, Goodship JA and Ruiz-Perez VL: The ciliary Evc/Evc2 complex interacts with Smo and controls Hedgehog pathway activity in chondrocytes by regulating Sufu/Gli3 dissociation and Gli3 trafficking in primary cilia. Hum Mol Genet. 22:124–139. 2013. View Article : Google Scholar : PubMed/NCBI

82 

Jia J, Kolterud A, Zeng H, Hoover A, Teglund S, Toftgård R and Liu A: Suppressor of Fused inhibits mammalian Hedgehog signaling in the absence of cilia. Dev Biol. 330:452–460. 2009. View Article : Google Scholar : PubMed/NCBI

83 

Zeng H, Jia J and Liu A: Coordinated translocation of mammalian Gli proteins and suppressor of fused to the primary cilium. PLoS One. 5:e159002010. View Article : Google Scholar : PubMed/NCBI

84 

Chen MH, Wilson CW, Li YJ, Law KK, Lu CS, Gacayan R, Zhang X, Hui CC and Chuang PT: Cilium-independent regulation of Gli protein function by Sufu in Hedgehog signaling is evolutionarily conserved. Genes Dev. 23:1910–1928. 2009. View Article : Google Scholar : PubMed/NCBI

85 

Ohlmeyer JT and Kalderon D: Hedgehog stimulates maturation of Cubitus interruptus into a labile transcriptional activator. Nature. 396:749–753. 1998. View Article : Google Scholar : PubMed/NCBI

86 

Paces-Fessy M, Boucher D, Petit E, Paute-Briand S and Blanchet-Tournier MF: The negative regulator of Gli, Suppressor of fused (Sufu), interacts with SAP18, Galectin3 and other nuclear proteins. Biochem J. 378:353–362. 2004. View Article : Google Scholar : PubMed/NCBI

87 

Cheng SY and Bishop JM: Suppressor of Fused represses Gli-mediated transcription by recruiting the SAP18-mSin3 corepressor complex. Proc Natl Acad Sci USA. 99:5442–5447. 2002. View Article : Google Scholar : PubMed/NCBI

88 

Lin C, Yao E, Wang K, Nozawa Y, Shimizu H, Johnson JR, Chen JN, Krogan NJ and Chuang PT: Regulation of Sufu activity by p66b and Mycbp provides new insight into vertebrate Hedgehog signaling. Genes Dev. 28:2547–2563. 2014. View Article : Google Scholar : PubMed/NCBI

89 

Barnfield PC, Zhang X, Thanabalasingham V, Yoshida M and Hui CC: Negative regulation of Gli1 and Gli2 activator function by Suppressor of fused through multiple mechanisms. Differentiation. 73:397–405. 2005. View Article : Google Scholar : PubMed/NCBI

90 

Kogerman P, Grimm T, Kogerman L, Krause D, Undén AB, Sandstedt B, Toftgård R and Zaphiropoulos PG: Mammalian suppressor-of-fused modulates nuclear-cytoplasmic shuttling of Gli-1. Nat Cell Biol. 1:312–319. 1999. View Article : Google Scholar : PubMed/NCBI

91 

Ruiz i Altaba A, Sánchez P and Dahmane N: Gli and hedgehog in cancer: Tumours, embryos and stem cells. Nat Rev Cancer. 2:361–372. 2002. View Article : Google Scholar : PubMed/NCBI

92 

Humke EW, Dorn KV, Milenkovic L, Scott MP and Rohatgi R: The output of Hedgehog signaling is controlled by the dynamic association between Suppressor of Fused and the Gli proteins. Genes Dev. 24:670–682. 2010. View Article : Google Scholar : PubMed/NCBI

93 

Merchant M, Vajdos FF, Ultsch M, Maun HR, Wendt U, Cannon J, Desmarais W, Lazarus RA, de Vos AM and de Sauvage FJ: Suppressor of fused regulates Gli activity through a dual binding mechanism. Mol Cell Biol. 24:8627–8641. 2004. View Article : Google Scholar : PubMed/NCBI

94 

Dunaeva M, Michelson P, Kogerman P and Toftgard R: Characterization of the physical interaction of Gli proteins with SUFU proteins. J Biol Chem. 278:5116–5122. 2003. View Article : Google Scholar : PubMed/NCBI

95 

Chen Y, Yue S, Xie L, Pu XH, Jin T and Cheng SY: Dual Phosphorylation of suppressor of fused (Sufu) by PKA and GSK3beta regulates its stability and localization in the primary cilium. J Biol Chem. 286:13502–13511. 2011. View Article : Google Scholar : PubMed/NCBI

96 

Wang Y, Li Y, Hu G, Huang X, Rao H, Xiong X, Luo Z, Lu Q and Luo S: Nek2A phosphorylates and stabilizes SuFu: A new strategy of Gli2/Hedgehog signaling regulatory mechanism. Cell Signal. 28:1304–1313. 2016. View Article : Google Scholar : PubMed/NCBI

97 

Zhou F, Huang D, Li Y, Hu G, Rao H, Lu Q, Luo S and Wang Y: Nek2A/SuFu feedback loop regulates Gli-mediated Hedgehog signaling pathway. Int J Oncol. 50:373–380. 2017. View Article : Google Scholar : PubMed/NCBI

98 

Liu C, Zhou Z, Yao X, Chen P, Sun M, Su M, Chang C, Yan J, Jiang J and Zhang Q: Hedgehog signaling downregulates suppressor of fused through the HIB/SPOP-Crn axis in Drosophila. Cell Res. 24:595–609. 2014. View Article : Google Scholar : PubMed/NCBI

99 

Lee DY, Deng Z, Wang CH and Yang BB: MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci USA. 104:20350–20355. 2007. View Article : Google Scholar : PubMed/NCBI

100 

Long H, Wang Z, Chen J, Xiang T, Li Q, Diao X and Zhu B: microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein (Sufu). Oncotarget. 6:38705–38718. 2015. View Article : Google Scholar : PubMed/NCBI

101 

Peng RQ, Wan HY, Li HF, Liu M, Li X and Tang H: MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-a-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7. J Biol Chem. 287:14301–14309. 2012. View Article : Google Scholar : PubMed/NCBI

102 

Browne G, Dragon JA, Hong D, Messier TL, Gordon JA, Farina NH, Boyd JR, VanOudenhove JJ, Perez AW, Zaidi SK, et al: MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells. Tumour Biol. 37:8825–8839. 2016. View Article : Google Scholar : PubMed/NCBI

103 

Min TH, Kriebel M, Hou S and Pera EM: The dual regulator Sufu integrates Hedgehog and Wnt signals in the early Xenopus embryo. Dev Biol. 358:262–276. 2011. View Article : Google Scholar : PubMed/NCBI

104 

Peng Y, Zhang X, Ma Q, Yan R, Qin Y, Zhao Y, Cheng Y, Yang M, Wang Q, Feng X, et al: MiRNA-194 activates the Wnt/β-catenin signaling pathway in gastric cancer by targeting the negative Wnt regulator, SUFU. Cancer Lett. 385:117–127. 2017. View Article : Google Scholar : PubMed/NCBI

105 

Bari R, Hartford C, Chan WK, Vong Q, Li Y, Gan K, Zhou Y, Cheng C, Kang G, Shurtleff S, et al: Genome-wide single-nucleotide polymorphism analysis revealed SUFU suppression of acute graft-versus-host disease through downregulation of HLA-DR expression in recipient dendritic cells. Sci Rep. 5:110982015. View Article : Google Scholar : PubMed/NCBI

106 

D'Amico D, Antonucci L, Di Magno L, Coni S, Sdruscia G, Macone A, Miele E, Infante P, Di Marcotullio L, De Smaele E, et al: Non-canonical Hedgehog/AMPK-mediated control of polyamine metabolism supports neuronal and medulloblastoma cell growth. Dev Cell. 35:21–35. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Huang D, Wang Y, Tang J and Luo S: Molecular mechanisms of suppressor of fused in regulating the hedgehog signalling pathway (Review). Oncol Lett 15: 6077-6086, 2018.
APA
Huang, D., Wang, Y., Tang, J., & Luo, S. (2018). Molecular mechanisms of suppressor of fused in regulating the hedgehog signalling pathway (Review). Oncology Letters, 15, 6077-6086. https://doi.org/10.3892/ol.2018.8142
MLA
Huang, D., Wang, Y., Tang, J., Luo, S."Molecular mechanisms of suppressor of fused in regulating the hedgehog signalling pathway (Review)". Oncology Letters 15.5 (2018): 6077-6086.
Chicago
Huang, D., Wang, Y., Tang, J., Luo, S."Molecular mechanisms of suppressor of fused in regulating the hedgehog signalling pathway (Review)". Oncology Letters 15, no. 5 (2018): 6077-6086. https://doi.org/10.3892/ol.2018.8142
Copy and paste a formatted citation
x
Spandidos Publications style
Huang D, Wang Y, Tang J and Luo S: Molecular mechanisms of suppressor of fused in regulating the hedgehog signalling pathway (Review). Oncol Lett 15: 6077-6086, 2018.
APA
Huang, D., Wang, Y., Tang, J., & Luo, S. (2018). Molecular mechanisms of suppressor of fused in regulating the hedgehog signalling pathway (Review). Oncology Letters, 15, 6077-6086. https://doi.org/10.3892/ol.2018.8142
MLA
Huang, D., Wang, Y., Tang, J., Luo, S."Molecular mechanisms of suppressor of fused in regulating the hedgehog signalling pathway (Review)". Oncology Letters 15.5 (2018): 6077-6086.
Chicago
Huang, D., Wang, Y., Tang, J., Luo, S."Molecular mechanisms of suppressor of fused in regulating the hedgehog signalling pathway (Review)". Oncology Letters 15, no. 5 (2018): 6077-6086. https://doi.org/10.3892/ol.2018.8142
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team